What Changed on an Emotional Face Recognition Task After Psilocybin With Support?
In an open-label study, J. B. Stroud and colleagues found that people with treatment-resistant depression recognized facial emotions faster one month after receiving psilocybin with psychological support. Seventeen patients completed the task at baseline and follow-up. Sixteen untreated controls completed it on the same schedule. The researchers reported a group-by-time interaction for recognition speed.
The result describes speed on a defined task
The task presented changing facial expressions. At baseline, the patients were slower than the controls. At follow-up, the patients responded faster than they had at baseline, while the controls did not show a statistically significant change in speed. The study did not include an additional task that could establish whether the change was specific to emotional faces or reflected a broader change in processing speed.
Practice, support, and symptom change
Repeating the task in the control group gave the researchers a comparison for simple repetition under those conditions. The controls were younger, however, and received neither a placebo intervention nor comparable support. That limits what the contrast can show about the drug’s specific contribution.
Within the patient group, greater improvement in recognition speed was associated with a greater reduction in anhedonia, the loss of interest or pleasure. That association offers a question for a controlled study. It leaves open whether either change caused the other or whether both reflected other changes during treatment.
Source
Stroud JB, Freeman TP, Leech R, et al. Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression. Psychopharmacology. 2018. DOI 10.1007/s00213-017-4754-y.



